Company Filing History:
Years Active: 2025
Title: Innovations in Cancer Treatment by Daniel Bottomly
Introduction
Daniel Bottomly is an accomplished inventor based in Beaverton, Oregon. He has made significant contributions to the field of medical research, particularly in the treatment of acute myeloid leukemia (AML). His work focuses on developing methods to treat this serious condition, especially in patients with specific gene mutations.
Latest Patents
Daniel Bottomly holds a patent for his invention titled "Treatments for mutations in acute myeloid leukemia." This patent outlines useful methods for treating AML in humans who present with gene mutations. His innovative approach aims to improve the effectiveness of treatments for this challenging disease.
Career Highlights
Bottomly is affiliated with Oregon Health & Science University, where he conducts his research and develops his inventions. His work has garnered attention for its potential to change the landscape of cancer treatment, particularly for those affected by AML.
Collaborations
Daniel collaborates with notable colleagues in his field, including Jeffrey Tyner and Cristina Tognon. Their combined expertise enhances the research and development of new treatment methodologies.
Conclusion
Daniel Bottomly's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes in acute myeloid leukemia. His work continues to inspire advancements in medical research and treatment options.